Breast Cancer and the Workforce: Talking to Employers and Medical Staff About Work (TEAMWork)

Full Title

MCT: Breast Cancer and the Workforce: Talking to Employers and Medical Staff About Work (TEAMWork)

Purpose

Chemotherapy can cause symptoms, such as nausea and fatigue, and some patients have difficulty working during this treatment. The purpose of this study is to learn more about how chemotherapy for breast cancer affects patients’ employment.

Researchers are assessing an early version of a mobile app, called TEAMWork (Talking to Employers And Medical staff about Work), which is designed to help breast cancer patients keep their jobs during and after chemotherapy. The app provides advice for patients to use when having conversations about breast cancer with their employers and their doctors.

In this study, patients with breast cancer who are about to receive chemotherapy or who are currently receiving treatment are being asked to tell researchers what aspects of the app work well, providing feedback that can be used to improve it.

Eligibility

To be eligible for this study, patients must meet several criteria, including but not limited to the following:

  • Patients must be undergoing or planning to receive chemotherapy for stage I-III breast cancer.
  • Patients must be employed full-time or part-time.
  • Patients must have a smartphone and use it to review the app.
  • This study is for patients age 18 to 64.

For more information about this study, please call 646-888-8151.

Protocol

18-217

Phase

Pilot

Disease Status

Newly Diagnosed

Investigator

Co-Investigators